Skip to Content
Dixon Kaufman, MD, PhD, FACS

Contact Dr. Kaufman

E-mail:
kaufman@surgery.wisc.edu

Phone:
(608) 265-6471

Mail:
600 Highland Avenue
BX7375 CLINICAL SCIENCE CENTER
Madison, WI 53792

Fax:
(608) 262-6280

Dixon Kaufman, MD, PhD, FACS

Ray D. Owen Professor of Surgery
Chairman, Division of Transplantation
Section of Kidney and Pancreas Surgery

Education

  • MD, University of Minnesota, 1983
  • NIH National Research Service Award, 1986 – 1989
  • Surgery Internship and Residency, University of Minnesota, 1983 – 1991
  • Transplantation Fellowship, University of Minnesota, 1991 – 1992
  • PhD, University of Minnesota, 1994

Board Certifications

  • Fellow, American College of Surgeons, 1995
  • UNOS-Certified Primary Transplant Surgeon, Pancreas, 1993
  • Diplomate, American Board of Surgery, 1992

Professional Activities

Faculty Appointments:

  • Ray D. Owen Professor and Chief, Division of Transplantation, School of Medicine and Public Health, University of Wisconsin – Madision, 2011 – present
  • Director, Transplantation Service Line, University of Wisconsin Hospital and Clinics, Madison, WI, 2011 – present

Dr. Kaufman is involved with the following professional societies:

  • American Surgical Association
  • American Society of Transplant Surgeons
  • Association for Academic Surgery
  • Fellow, American College of Surgeons
  • Cell Transplant Society, Founding Member
  • Central Surgical Association
  • International Pancreas and Islet Association, Founding Member
  • Society of University Surgeons
  • The Surgical Biology Club I
  • Transplantation Society

Leadership Roles in Transplantation

Dr. Kaufman has held leadership positions in many facets of the transplant field. He has been very active with the American Society of Transplant Surgeons (ASTS) and has served as Chair of the Education Committee, the Executive Program Committee Chair for the American Transplant Congress, and on the Council of the ASTS. Dr. Kaufman is also very active with the United Network for Organ Sharing (UNOS). He was past Chair of the Pancreas/Islet Transplant Committee, served on the MPSC Committee and currently is Councilor of UNOS Region 7 and a member of the Executive Board. Dr. Kaufman is an associate editor for the American Journal of Transplantation, Transplantation Journal, and Clinical Transplantation Journal.

Clinical Specialties

Dr. Kaufman is certified by the American Board of Surgery in General Surgery. Dr Kaufman’s clinical focus has been on kidney, pancreas, and islet transplantation. He was the first pancreas transplant surgeon in North America to conduct and publish studies regarding steroid-free immunosuppression in pancreas transplantation, and the first to describe the use of alemtuzumab in pancreas transplants.

Research Interests

Dr. Kaufman’s experimental clinical research has focused on immunosuppression minimization in kidney transplant recipients, and human clinical trials of islet transplantation. His basic research efforts have focused on development of a tolerance induction protocol in large animals. It is supported by an NIH UO-1 award as part of the Non-human Primate Tolerance Study Group Consortium.

Active Clinical Trials
  • A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
    Principal Investigator(s): Dixon Kaufman, MD, PhD, FACS
    Status: Active, not recruiting
    [ClinicalTrials.gov: NCT01780844]
    More Information
  • Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients: Efficacy of Islet After Kidney Transplantation (CIT-06)
    Principal Investigator(s): Dixon Kaufman, MD, PhD, FACS
    Status: Active, not recruiting
    [ClinicalTrials.gov: NCT00468117]
    More Information
  • Randomized, Open Label, Multicenter Study of Belatacept-based Early Steroid Withdrawal Regimen With Alemtuzumab or rATG Induction Compared to Tacrolimus-based Early Steroid Withdrawal Regimen With rATG Induction in Renal Transplantation
    Principal Investigator(s): Dixon Kaufman, MD, PhD, FACS
    Status: Recruiting
    [ClinicalTrials.gov: NCT01729494]
    More Information

Recent Publications
  • Foreword.
    Kaufman DB
    Chimerism 2016 Apr 22; ():0.
    [PubMed ID: 27104856]
    More Information
  • Outpatient Management of Delayed Graft Function Is Associated With Reduced Length of Stay Without an Increase in Adverse Events.
    Muth BL, Astor BC, Turk J, Mohamed M, Parajuli S, Kaufman DB, Mandelbrot DA, Djamali A
    Am. J. Transplant. 2016 May; 16(5):1604-11.
    [PubMed ID: 26700736]
    More Information
  • Pancreas Transplantation in Older Patients is Safe, but Patient Selection is Paramount.
    Scalea JR, Redfield RR, Arpali E, Leverson G, Sollinger HW, Kaufman DB, Odorico JS
    Transpl. Int. 2016 Feb 9.
    [PubMed ID: 26859581]
    More Information
  • Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria.
    Redfield RR, Ellis TM, Zhong W, Scalea JR, Zens TJ, Mandelbrot D, Muth BL, Panzer S, Samaniego M, Kaufman DB, Astor BC, Djamali A
    Hum. Immunol. 2016 Apr; 77(4):346-52.
    [PubMed ID: 26867813]
    More Information
  • When Do DCD Donors Die?: Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United States.
    Scalea JR, Redfield RR, Rizzari MD, Bennett R, Anderson ME, Anderson JE, Kaufman DB, Sollinger HW, Fernandez LA, D'Alessandro AM, Mezrich J
    Ann. Surg. 2016 Feb; 263(2):211-6.
    [PubMed ID: 26181480]
    More Information
  • Digital Image Analysis to Assess Quantity and Morphological Quality of Isolated Pancreatic Islets.
    Wang LJ, Kaufman DB
    Cell Transplant 2015 Nov 25.
    [PubMed ID: 26610269]
    More Information
  • The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).
    Shin JI, Palta M, Djamali A, Kaufman DB, Astor BC
    Transplantation 2015 Nov 12.
    [PubMed ID: 26566058]
    More Information
  • Older kidney transplant patients experience less antibody-mediated rejection: a retrospective study of patients with mild to moderate sensitization.
    Scalea JR, Redfield RR, Muth BL, Mohamed M, Wilson NA, Ellis TM, Kaufman DB, Djamali A
    Clin Transplant 2015 Dec; 29(12):1090-7.
    [PubMed ID: 26361077]
    More Information
  • Predictors and outcomes of delayed graft function after living-donor kidney transplantation.
    Redfield RR, Scalea JR, Zens TJ, Muth B, Kaufman DB, Djamali A, Astor BC, Mohamed M
    Transpl. Int. 2016 Jan; 29(1):81-7.
    [PubMed ID: 26432507]
    More Information
  • C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
    Yell M, Muth BL, Kaufman DB, Djamali A, Ellis TM
    Transplantation 2015 Jun; 99(6):1151-5.
    [PubMed ID: 25839705]
    More Information

webmaster@surgery.wisc.edu Copyright © 2016 The Board of Regents of the University of Wisconsin System